What does Belerx do?
BELERX is a pharmaceutical company that specializes in the development and commercialization of innovative therapies. It focuses on providing solutions for unmet medical needs, particularly in oncology and other critical therapeutic areas. The company is committed to improving patient outcomes through advanced research and collaboration.
- Signals
-
ProfitableProfitable € 636K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 2.89MStrong equity provides a buffer against setbacks.
Low riskLow risk 96.7%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 22.81A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 642KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 783KPositive EBITDA: operating activities are profitable.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
793K
|
€
717K
|
€
560K
|
€
739K
|
|
|
€
783K
|
€
708K
|
€
551K
|
€
728K
|
|
|
€
636K
|
€
461K
|
€
402K
|
€
477K
|
|
|
€
2.89M
|
€
2.26M
|
€
2.11M
|
€
1.71M
|
|
|
96.70%
|
85.98%
|
95.01%
|
94.22%
|
|
|
€
99K
|
€
368K
|
€
111K
|
€
105K
|
|
|
€
1.75M
|
€
1.30M
|
€
1.35M
|
€
860K
|
Publications 5
All publications- Maatschappelijke Zetel - Diversen 25/08/2021
- Maatschappelijke Zetel 19/07/2021
- Maatschappelijke Zetel 15/04/2021
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Wijziging Rechtsvorm 08/06/2020
- Rubriek Oprichting (Nieuwe Rechtspersoon, Opening Bijkantoor, Enz...) 26/07/2018
Frequently asked questions
Answers to the most common questions about Belerx, based on official government data and the filed annual accounts.
What is the VAT number of Belerx?
The VAT number of Belerx is BE0700.354.054.
When was Belerx established?
Belerx was founded in 24-07-2018.
What is the official address of Belerx?
The official address of Belerx is Mortselsesteenweg 142 Hove 2540.
What is the legal form of Belerx?
The juridical form of Belerx is Private limited company (BV/SRL).
What is the annual revenue of Belerx?
The 2025 accounts of Belerx do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Belerx do?
BELERX is a pharmaceutical company that specializes in the development and commercialization of innovative therapies. It focuses on providing solutions for unmet medical needs, particularly in oncology and other critical therapeutic areas. The company is committed to improving patient outcomes through advanced research and collaboration.
Is Belerx a reliable company?
Belerx is a registered Rechtspersoon with company number 0700.354.054 and can be verified through the official CBE database.
What is the credit limit of Belerx?
The estimated credit limit of Belerx is €987,626.
Is Belerx still active?
Belerx currently has the status "Normal situation" and is active.